People channel feed

Af­ter biotech im­plo­sions, ex-Mil­len­ni­um chief Deb­o­rah Dun­sire is tak­ing the helm at Lund­beck

7 years ago

Sar­co­ma ex­pert George Demetri grades the lat­est state­ment on Nanobi­otix's late-stage drug NBTXR3

7 years ago
R&D
Pharma

Meet Jen­nifer Pet­ter: Boston start­up Ar­rakis cel­e­brates a big per­son­al tran­si­tion for top ex­ec

7 years ago

In high-lev­el reshuf­fle, Roche gives James Sabry the glob­al reins on deal-mak­ing — over­see­ing pRED and gRED

7 years ago
Peer Review

Ex-Puma ex­ec sen­tenced to prison stretch on in­sid­er-trad­ing con­vic­tion — 'greed' made me do it

7 years ago
Pharma

Buf­fett, Di­mon and Be­zos find their mir­a­cle man, charged with fix­ing a bro­ken health­care sys­tem

8 years ago

From top an­a­lyst to CFO: Cowen’s Er­ic Schmidt leaps in­to the top ranks of biotech’s lat­est overnight sen­sa­tion

8 years ago

For­mer biotech an­a­lyst Ja­son Napo­dano sen­tenced to a short stretch in a fed­er­al prison for se­cu­ri­ties fraud

8 years ago

Blame the ozan­i­mod fi­as­co on the Re­cep­tos team? Just wait a sec, says ex-CEO, who sold the com­pa­ny to Cel­gene for $7.2B

8 years ago
Pharma

Promi­nent can­cer bi­ol­o­gist In­der Ver­ma re­signs from Salk in wake of sex­u­al ha­rass­ment al­le­ga­tions

8 years ago

GSK’s high-lev­el man­age­ment makeover con­tin­ues as CEO Em­ma Walm­s­ley over­sees chang­ing of the guard

8 years ago

Af­ter cash fun­nel­ing scan­dal, biotech bil­lion­aire Soon-Sh­iong charges on with Nant IPO

8 years ago
Financing

On an ex­ec­u­tive hir­ing spree, Sarep­ta snags Bio­gen's Gilmore O'Neill as new CMO

8 years ago

No­to­ri­ous ac­tivist in­vestor Carl Ic­ahn buys small stake in Al­ler­gan

8 years ago

FDA vet — and Wood­cock neme­sis — John Jenk­ins is step­ping over to a new role as a board mem­ber at Cor­bus Phar­ma

8 years ago

Prep­ping a drug launch, Zai Lab poach­es As­traZeneca’s top can­cer drug sales ex­ec in Chi­na

8 years ago
China

Fol­low­ing FDA win, Por­to­la los­es CEO William Lis

8 years ago

Sarep­ta snags its part­ner's CSO, Louise Rodi­no-Kla­pac, to lead new gene ther­a­py unit

8 years ago

Cel­gene CEO Mark Alles poach­es a top J&J ex­ec for his se­nior crew dur­ing a C-suite makeover

8 years ago

Iron­wood dodges a Den­ner board seat, but the ac­tivist in­vestor still has words of ad­vice

8 years ago
R&D

No­var­tis los­es a head hon­cho, with US on­col­o­gy head Bill Hin­shaw ex­it­ing for new gig at Ax­cel­la

8 years ago

Sanofi fires back at Roseanne: 'racism is not a side ef­fec­t' of Am­bi­en

8 years ago

Arc­turus' ex-CEO tri­umphs, oust­ing board that oust­ed him

8 years ago

Top re­search ex­ecs from Te­va, Al­ler­gan re­cruit­ed to help lead Ax­o­vant out of the R&D waste­land

8 years ago
R&D
Peer Review
First page Previous page 87888990919293 Next page Last page
A service from the Financial Times